Impaired olfaction is a recognised non-motor feature and considered to be a reliable
biomarker for assisting with diagnosing Parkinson’s disease (PD). In addition, cardiovascular
autonomic dysfunction is increasingly accepted in PD as a major non-motor sign. Assessment
of both these non-motor symptoms may increase the detection of PD and thus aid management.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Autonomic Neuroscience: Basic and ClinicalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Received:
May 15,
2013
Identification
Copyright
© 2013 Published by Elsevier Inc.
